| Date Filed | Type | Description |
| 06/12/2023 |
SC 13D/A
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE reports a 3.9% stake in EPSILON ENERGY LTD. |
| 11/23/2022 |
SC 13D
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE reports a 6% stake in IRIDEX CORPORATION |
| 09/01/2021 |
SC 13D/A
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE reports a 5% stake in Iridex Corporation |
| 07/02/2021 |
SC 13D/A
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE reports a 6.3% stake in Iridex Corporation |
| 04/13/2021 |
SC 13D/A
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE reports a 7.3% stake in Iridex Corporation |
| 01/24/2018 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 10/10/2017 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 09/23/2016 |
SC 13D/A
| CareDx, Inc. reports a 7.9% stake in CAREDX, INC. |
| 10/02/2012 |
SC 13D/A
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE reports a 4.9% stake in The Spectranetics Corporation |
| 08/17/2012 |
SC 13D/A
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE reports a 5.6% stake in The Spectranetics Corporation |
| 05/26/2011 |
SC 13D/A
| Form SC 13D - General statement of acquisition of beneficial ownership [amend] |
| 05/17/2011 |
SC 13D/A
| SPECTRANETICS CORP has filed a Schedule 13D for The Spectranetics Corporation |
| 04/08/2011 |
SC 13D/A
| DUSA PHARMACEUTICALS INC has filed a Schedule 13D for Dusa Pharmaceuticals, Inc. |
| 11/02/2010 |
SC 13D
| SPECTRANETICS CORP has filed a Schedule 13D for The Spectranetics Corporation |
| 05/07/2010 |
SC 13D/A
| SENORX INC has filed a Schedule 13D for SenoRx, Inc. |
| 06/29/2009 |
SC 13D/A
| Form SC 13D/A -- General statement of acquisition of beneficial ownership [amend] |
| 02/10/2009 |
SC 13D/A
| Form SC 13D/A -- General statement of acquisition of beneficial ownership [amend] |
| 01/08/2009 |
SC 13D
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE has filed a Schedule 13D for Iridex Corporation |
| 12/11/2008 |
SC 13D
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE has filed a Schedule 13D for Dusa Pharmaceuticals, Inc. |
| 12/11/2008 |
SC 13D
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE has filed a Schedule 13D for SenoRx, Inc. |
| 10/11/2007 |
SC 13D/A
|
SEC Filing in the EDGAR database
|
| 12/09/2005 |
SC 13D
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE reports a 0% stake in |
| 11/08/2000 |
SC 13D
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE reports a 0% stake in |
| 01/25/2000 |
SC 13D/A
| ARONEX PHARMACEUTICALS INC reports a 5% stake in ARONEX PHARMACEUTICALS, INC. |
| 01/20/2000 |
SC 13D/A
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE reports a 0% stake in |
| 07/30/1999 |
SC 13D/A
| ARONEX PHARMACEUTICALS INC reports a 6.5% stake in ARONEX PHARMACEUTICALS, INC. |
| 02/26/1999 |
SC 13D/A
| ARONEX PHARMACEUTICALS INC reports a 8.2% stake in ARONEX PHARMACEUTICALS, INC. |
| 06/05/1998 |
SC 13D
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE reports a 0% stake in |
| 12/18/1997 |
SC 13D/A
| ARONEX PHARMACEUTICALS INC reports a 8.8% stake in ARONEX PHARMACEUTICALS, INC. |
| 12/03/1997 |
SC 13D/A
| ARONEX PHARMACEUTICALS INC reports a 6.6% stake in ARONEX PHARMACEUTICALS, INC. |
| 10/20/1997 |
SC 13D
| ARONEX PHARMACEUTICALS INC reports a 5.3% stake in ARONEX PHARMACEUTICALS, INC. |